BSE Live
Oct 03, 10:21Prev. Close
5710.70
Open Price
5788.45
Bid Price (Qty.)
5793.40 (8)
Offer Price (Qty.)
5798.00 (101)
NSE Live
Oct 03, 10:21Prev. Close
5710.00
Open Price
5759.50
Bid Price (Qty.)
5795.00 (348)
Offer Price (Qty.)
5796.00 (52)
Balance Sheet of Divis Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | |
Total Share Capital | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | |
Reserves and Surplus | 7,263.60 | 6,920.22 | 5,906.56 | 5,355.82 | 4,297.05 | |
Total Reserves and Surplus | 7,263.60 | 6,920.22 | 5,906.56 | 5,355.82 | 4,297.05 | |
Total Shareholders Funds | 7,316.69 | 6,973.31 | 5,959.65 | 5,408.91 | 4,350.14 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.47 | |
Deferred Tax Liabilities [Net] | 273.96 | 221.18 | 192.69 | 130.03 | 149.20 | |
Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Provisions | 20.52 | 13.17 | 14.95 | 15.30 | 11.57 | |
Total Non-Current Liabilities | 294.48 | 234.35 | 207.64 | 145.33 | 161.24 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 33.63 | 105.60 | 63.11 | 35.74 | 41.42 | |
Trade Payables | 580.34 | 483.31 | 405.65 | 442.30 | 230.42 | |
Other Current Liabilities | 286.51 | 242.50 | 170.79 | 176.52 | 239.46 | |
Short Term Provisions | 2.46 | 1.11 | 0.94 | 1.28 | 4.81 | |
Total Current Liabilities | 902.94 | 832.52 | 640.49 | 655.84 | 516.12 | |
Total Capital And Liabilities | 8,514.11 | 8,040.18 | 6,807.78 | 6,210.08 | 5,027.50 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 2,772.66 | 2,083.39 | 1,989.33 | 1,555.70 | 1,435.71 | |
Intangible Assets | 3.60 | 4.05 | 6.55 | 3.25 | 2.93 | |
Capital Work-In-Progress | 919.69 | 491.91 | 119.76 | 443.57 | 263.91 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 3,695.95 | 2,579.35 | 2,115.64 | 2,002.52 | 1,702.55 | |
Non-Current Investments | 7.37 | 554.62 | 7.37 | 8.37 | 2.83 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 35.00 | 34.04 | 0.00 | 18.56 | 203.00 | |
Other Non-Current Assets | 114.62 | 224.68 | 130.86 | 141.48 | 0.00 | |
Total Non-Current Assets | 3,852.94 | 3,392.69 | 2,253.87 | 2,170.93 | 1,908.38 | |
CURRENT ASSETS | ||||||
Current Investments | 971.35 | 1,398.34 | 1,889.29 | 1,630.72 | 802.52 | |
Inventories | 1,744.17 | 1,663.18 | 1,281.39 | 1,255.76 | 1,162.89 | |
Trade Receivables | 1,533.21 | 1,282.24 | 1,112.11 | 1,002.89 | 966.12 | |
Cash And Cash Equivalents | 107.36 | 105.20 | 91.48 | 66.47 | 57.67 | |
Short Term Loans And Advances | 0.09 | 0.11 | 14.86 | 5.53 | 124.52 | |
OtherCurrentAssets | 304.99 | 198.42 | 164.78 | 77.78 | 5.40 | |
Total Current Assets | 4,661.17 | 4,647.49 | 4,553.91 | 4,039.15 | 3,119.12 | |
Total Assets | 8,514.11 | 8,040.18 | 6,807.78 | 6,210.08 | 5,027.50 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 1,223.83 | 1,031.35 | 278.90 | 388.81 | 273.83 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 844.54 | |
Stores, Spares And Loose Tools | 1,159.72 | 1,218.68 | 848.52 | 1,025.95 | 1.85 | |
Trade/Other Goods | 1,159.72 | 1,218.68 | 848.52 | 1,025.95 | 1.85 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 17.14 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 23.94 | 21.83 | 55.71 | 1.39 | 12.04 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | 3,219.80 | |
Other Earnings | 4,483.23 | 4,123.76 | 3,235.90 | 3,538.39 | 7.24 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 39.67 | 39.67 | 39.67 | 39.67 | 39.67 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | 547.25 | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 7.37 | 7.37 | 7.37 | 8.37 | 2.83 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 971.35 | 1,398.34 | 1,889.29 | 1,630.72 | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | 802.52 |
10.09.2025
Reduce Divis Laboratories; target of Rs 5400: Geojit Financial Services
07.08.2025
Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher
07.08.2025
Divis Labs Standalone June 2025 Net Sales at Rs 2,357.00 crore, up 14.25% Y-o-Y
23.05.2025
Accumulate Divis Laboratories; target of Rs 7518: Deven Choksey
07.08.2025
Divis Labs Standalone June 2025 Net Sales at Rs 2,357.00 crore, up 14.25% Y-o-Y
19.05.2025
Divis Labs Consolidated March 2025 Net Sales at Rs 2,585.00 crore, up 12.24% Y-o-Y
19.05.2025
Divis Labs Standalone March 2025 Net Sales at Rs 2,536.00 crore, up 12.26% Y-o-Y
03.02.2025
Divis Labs Consolidated December 2024 Net Sales at Rs 2,319.00 crore, up 25.01% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill